Several personal care products containing ingredients like aloe vera, jojoba oil, and orange oil are likely to be banned in India. An exper...

India's drug regulator has banned the manufacture and sale of 35 fixed dose combinations (FDCs), citing concerns over patient safety and po...

India's drug regulator, CDSCO, has ordered a halt to the production, sale, and distribution of 35 fixed-dose combination (FDC) drugs due to...

The government is likely to ban more fixed dose combinations (FDCs) this month. An expert committee found that these FDCs lack therapeutic ...

The Indian government recently banned 156 fixed-dose combination drugs, citing health risks. An expert committee found these combinations l...

FDCs are medicines that combine two or more drugs into a single dosage. The union health and family welfare ministry on Thursday issued a g...

In a letter dated December 18, the drug regulator said that FDC (fixed-dose combination) chlorpheniramine maleate and phenylephrine should ...

A committee had been set up under the chairmanship of CK Kokate, former vice-chancellor of KLE University, Belgaum, to review the safety, e...

The expert committee said that there is "no therapeutic justification for this FDC (fixed dose combination) and the FDC may involve risk to...

The WHO in its revision exercise of antibiotics have grouped them into three categories– access, watch and reserve. WHO recommends that ant...

Wockhardt moved the court as its anti-inflammatory drug -- Ace Proxyvon -- is one of the FDC medicines affected by the Centre's September 7...

This report will be sent to the health ministry in the next two weeks, following which the government will decide the fate of these drugs, ...

Over 70 fixed dose combination (FDC) medicine brands marketed by 16 pharma companies have been seized in an ongoing raid of two drug manufa...

Govt defends process followed to ban FDCs, argues that these medicines are not fit for consumption.

While any initiative to ensure the safety and efficacy of medicines in India must be lauded, it is a big concern that India’s drug regulato...

Pfizer and Abbott and domestic companies including Alkem, Ipca and MacLeods, and is likely to be contested by companies, sources say.

The drug controller had earlier directed the state drug controllers to withdraw 294 FDCs which got licences without approval of DCGI.